公司概覽
業務類別 Biotechnology
業務概覽 Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
公司地址 200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428
電話號碼 +1 267 824-2827
傳真號碼 --
公司網頁 https://www.madrigalpharma.com
員工數量 915
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. William John Sibold Director, President and Chief Executive Officer 美元 918.53K 28/04/2026
Ms. Mardi C. Dier Executive Vice President and Chief Financial Officer 美元 566.04K 28/04/2026
Dr. David Soergel, M.D. Executive Vice President and Chief Medical Officer 美元 418.18K 28/04/2026
Ms. Carole Huntsman Executive Vice President and Chief Commercial Officer 美元 540.31K 28/04/2026
Ms. Shannon T. Kelley Executive Vice President and Chief Legal Counsel 美元 535.17K 28/04/2026
Ms. Rita Thakkar Senior Vice President and Chief Accounting Officer -- 12/03/2026
 
董事會成員
董事會 職務 更新日期
Dr. John C. Reed,M.D.,PhD Director 12/08/2026
Mr. Julian C. Baker Chairman of the Board 28/04/2026
Dr. Jacqualyn A. Fouse, PhD Independent Director 28/04/2026
Dr. Rebecca A. Taub,M.D. Director 28/04/2026
Dr. Richard S. Levy,M.D. Independent Director 28/04/2026
Mr. Daniel J. Brennan Independent Director 28/04/2026
Mr. William John Sibold Director, President and Chief Executive Officer 28/04/2026
Mr. James M. Daly Independent Director 28/04/2026
Dr. Raymond Cheong, M.D. Independent Director 28/04/2026
 
所屬ETF (更新日期: 14/11/2026 02:04)
代號 名稱 佔比% ▼ 持有日期
DFUSDimensional US Equity Market ETF<0.000001%24/08/2026
DWASInvesco Dorsey Wright SmallCap Momt ETF<0.000001%01/04/2026
FDLSInspire Fidelis Multi Factor ETF<0.000001%23/03/2026
FEACFidelity Enhanced U.S. All-Cap Eq ETF<0.000001%26/03/2026
FFSMFidelity Fundamental Small-Mid Cap ETF<0.000001%28/02/2026
FLDZTrueShares Patriot Defense ETF<0.000001%10/07/2026
FSMDFidelity Small-Mid Multifactor ETF<0.000001%21/08/2026
FSMLFranklin Small Cap Enhanced ETF<0.000001%09/07/2026
FTXHFirst Trust Nasdaq Pharmaceuticals ETF<0.000001%22/03/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF<0.000001%29/06/2026
HDGProShares Hedge Replication<0.000001%29/06/2026
ISCViShares Morningstar Small-Cap Value ETF<0.000001%04/03/2026
ITWOProShares Russell 2000 High Income ETF<0.000001%29/06/2026
IWMiShares Russell 2000 ETF<0.000001%26/06/2026
IWOiShares Russell 2000 Growth ETF<0.000001%26/06/2026
KATScharf ETF<0.000001%29/08/2025
LFSCF/m Emerald Life Sciences Innovation ETF<0.000001%26/03/2026
MHIGMilliman Healthcare Inflation Guard ETF<0.000001%20/08/2026
MHIPMilliman Healthcare Inflation Plus ETF<0.000001%20/10/2026
NXTISimplify Next Intangible Core Index ETF<0.000001%16/03/2026
  1    2    3    4    5   6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.